Detection of molecular signatures of homologous recombination deficiency in endometrial cancer (180)Xiaqin Cheng, Jundong Li, Ya Qiu et al.|Gynecologic Oncology|2022Cited by 0
Overall survival and subsequent therapy from a phase II study of sintilimab and anlotinib in patients with advanced or recurrent endometrial cancer.Zhen Zeng, Jundong Li, Lan-Yue Cui et al.|Journal of Clinical Oncology|2023Cited by 0